News

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...
Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...
San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to ...